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1. Introduction 
Pepsin is inhibited by a basic polypeptide, liberated 
from pepsinogen during the activation process and 
isolated in a crystalline form by Herriott [l] , and also 
by certain synthetic polyamino acids - poly-L-lysine, 
polyornithine and poly-p-aminophenylalanine [2,3]. 
Only basic high molecular compounds have so far been 
found to act as pepsin inhibitors; neutral or acidic 
polyamino acids, such as polyDL-alanine and poly- 
aspartic and polyglutamic acids proved to be inactive 
Katchalski et al. [2] thus assumed that an inactive 
enzyme-inhibitor complex is formed by electrostatic 
attraction between the negatively charged pepsin mole- 
cule and the positively charged inhibitor compound. 
The present communication describes the effect of 
polyvinylpyrrolidone [PVP] , a neutral molecule [4], 
on enzymatic reactions catalyzed by pepsin. 
2. Materials and methods 
The reagents and enzymes were purchased from the 
commercial source indicated: polyvinylpyrrolidone, 
average M.W. 10,000; 40,000 and 360,000, Sigma Che- 
mical Company, St. Louis MO., U.S.A.; I-vinyl-2-pyr- 
rolidine, Eastman Kodak Co., Rochester, N.Y., U.S.A.; 
crystallized porcine pepsin and crystallized chymo- 
trypsin, Armour Research Division, Chicago, Ill., U.S.A.; 
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trypsin (20,000 U./g), ovalbumin and casein (Ham- 
marsten), (E.Merck A.G., Darmstadt, Germany). The 
hemoglobin was prepared by crystallization from 
horse red blood cells. 
Proteolytic activity was determined photometrical- 
ly according to Anson [ 51 and expressed as micro- 
equivalents of tyrosine found in the trichloroacetic 
acid (3.1%) filtrate of the digest. Milk clotting activity 
was determined as by Herriott [ 1 ] using a 20% solu- 
tion of dried milk (“Reina de1 Campo”) in acetate 
buffer. A more detailed description of the experimen- 
tal conditions is given in the legends to the figures. 
3. Results and discussion 
Herriott’s naturally occurring polypeptide, whose 
basic nature has been confirmed by its amino acid 
composition, amide-N content and chromatographic 
properties [7], inhibits pepsin action between pH 5 and 
6 as revealed by the milk clotting test [l] . At a higher 
hydrogen ion concentration, pepsin hydrolyses this 
peptide. Unlike the natural pepsin inhibitor, but like 
the other basic high polymers mentioned, PVP exerts 
within the lower pH-range an inhibition of pepsin ac- 
tion on hemoglobin (fig. 1). Double reciprocal plots 
of 1 /activity versus 1 /substrate (fig. 1) suggest a com- 
petitive inhibition with respect to the substrate. 
The PVP inhibition of pepsin action is not due to 
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Fig. 1. Polyvinylpyrrolidone inhibition of pepsin proteolysis 
of hemoglobin. Substrate concentration was varied as indicated 
using 15 mg of PVP (average M.W. 40,000) as inhibitor. Incu- 
bation was at 37.5’ for 10 min with 0.1 mg pepsin at pH 1.0 
(HCl-KC1 buffer) in a total volume of 6.0 ml. Pepsin activity 
was determined photometrically as by Anson [ 5 ] and expres- 
sed in microequivalents of tyrosine liberated per minute. Re- 
sults are corrected for blank values. The same results are 
shown in the insert as a double reciprocal plot of l/activity 
versus l/substrate. 
changes in viscosity of the digestion medium, since 
PVP samples of average molecular weight 10,000 to 
360,000 in corresponding experiments produced the 
same loss of enzymatic activity when added in the 
amount of 3.5 mg/ml to each incubation medium. 
When PVP was treated with hot hydrochloric acid 
(8 M, 45 hr at 1 lo”), a treatment which gives a slightly 
hydrolyzed product (3.0 to 7.7%) as revealed by al- 
coholic basic titration [8], the action of the inhibitor 
was not enhanced. No inhibition was found when 
hemoglobin, under the conditions described above 
(fig. l), was incubated with pepsin at pH 1 in the 
presence of 6 to 2 1 mg of the monomer, 1 -vinyl-Z 
pyrrolidone. 
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Fig. 2. Influence of hydrogen ion concentration on the effect 
of polyvinylpyrrolidone on pepsin-catalyzed proteolysis and 
milk clotting. Proteolysis: acetate buffers (0.2 M), previously 
adjusted to the indicated pH with HCl or NaOH, respectively. 
Ovalbumin (20 mg) and hemoglobin (2.4 mg N) were the sub- 
strates in a total volume of 6.0 ml containing 0.2 mg pepsin. 
Milk clotting: activity was determined according to Herriott 
[6] using 5 .O ml of a 20% solution of milk powder (Reina de1 
Campo) in acetate buffer (1 M) of the indicated pH in a total 
volume of 6.0 ml containing 6.25 mg of pepsin. PVP (15 mg) 
effector activity in both experimental groups is expressed as 
percentage of the values obtained without the effector at the 
same pH. 
The inhibition of proteolysis was ob’ ;J over the 
whole “physiological pH-range” of p, ,!bIn action 
(fig. 2). At higher pH values, a leq degree of inhl- 
bition was found. 
By use of the milk clotting test between pH 5 and 
6, a striking difference is observed between the effects 
on pepsin action of the basic natural pepsin inhibitor 
and PVP. As shown in fig. 2, PVP apparently enhances, 
whereas under the same experimental conditions the 
natural inhibitor decreases, the milk clotting activity 
of the enzyme [l] . The effector function of PVP 
seems to be restricted to pepsin action. At least, 
trypsin and chymotrypsin are not influenced by PVP 
in their proteolytic actions at pH 7.6 and 8.0, respec- 
tively, at concentrations at which the pepsin activity 
at pH 1 .d is evidently reduced (fig. 3). The mecha- 
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Fig. 3. Effects of polyvinylpyrrolidone on pepsin, chymo- 
trypsin and trypsin-catalyzed proteolysis. The enzymes used 
in 6.0 ml of test volume were: pepsin 0.1 mg, chymotrypsin 
0.2 mg, trypsin 0.2 mg. Incubation was for 10 min at 37O. Pep- 
sin (u) acted on native hemoglobin (2.4 mg N) at pH 1.0 
in HCl-KC1 buffer, trypsin (-) on urea-denatured hemoglo- 
bin (2.4 mg N) in phosphate buffer, pH 7.5, and chymotrypsin 
(-) on casein (20 mg) in borate buffer, pH 8.0. Enzyma- 
tic activity was determined photometrically according to Anson 
(51. The action of PVP in the indicated amount was expressed 
as percentage of the activity obtained in control experiments 
without PVP. 
nism by which PVP exhibits inhibition of the proteol- 
ytic action of pepsin on ovalbumin and hemoglobin, 
but activates the milk clotting action, obviously must 
be different from that involved in the pepsin interac- 
tion with basic polymers, since the vinyl polymer is 
a neutral molecule and has no charged groups. Further- 
more, the PVP molecule cannot act as a hydrogen 
donor in the formation of hydrogen bonds. However, 
the ‘,CO groups of its alternating cyclic lactam side 
chains may serve as acceptors of hydrogen supplied 
by an appropiate donor molecule. By this means, and 
assisted by hydrophobic bonding, an inactive PVP- 
pepsin complex can be formed. It is assumed that 
tyrosyl residues are involved in this type of interac- 
tion, and especially those which are associated with 
the pepsin activity [ 1, 0] . Support for such assump- 
tion comes from binding studies with synthetic dyes, 
the results of which indicate that certain of these com- 
pounds are bound to the PVP molecule by establishing 
hydrogen bonds between their phenolic hydroxyls and 
the carbonyl groups of the polymer [lo] 
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